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a b s t r a c t
Inhalation is the main pathway of ZnO exposure in the occupational environment but only few studies
have addressed toxic effects after pulmonary exposure to ZnO nanoparticles (NP). Here we present re-
sults from three studies of pulmonary exposure and toxicity of ZnO NP in mice. The studies were pre-
maturely terminated because interim results unexpectedly showed severe pulmonary toxicity. High
bolus doses of ZnO NP (25 up to 100 mg; 1.4 mg/kg) were clearly associated with a dose dependent
mortality in the mice. Lower doses (6 mg; 0.3 mg/kg) elicited acute toxicity in terms of reduced weight
gain, desquamation of epithelial cells with concomitantly increased barrier permeability of the alveolar/
blood as well as DNA damage. Oxidative stress was shown via a strong increase in lipid peroxidation and
reduced glutathione in the pulmonary tissue. Two months post-exposure revealed no obvious toxicity for
12.5 and 25 mg on a range of parameters. However, mice that survived a high dose (50 mg; 2.7 mg/kg) had
an increased pulmonary collagen accumulation (ﬁbrosis) at a similar level as a high bolus dose of
crystalline silica. The recovery from these toxicological effects appeared dose-dependent. The results
indicate that alveolar deposition of ZnO NP may cause signiﬁcant adverse health effects.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
1. Introduction
Zinc oxide (ZnO) nanoparticles (NP) are extensively used in
consumer products. Worldwide production is estimated at 0.1e1.2
million tons per year (Das et al., 2011; Kumar and Dhawan, 2013).
ZnO and/or ZnO NP are used in numerous products like cosmetics,
sun screens, plastics, rubber, ceramics, cement, glass, paints, lu-
bricants, electronic sensor and solar cells. Furthermore, ZnO are
added to fertilizers and animal food as a source for the
micronutrient (Zn) essential for hundreds of enzymes (Baxter and
Aydil, 2005; Pan et al., 2001; Pinnell et al., 2000; Ma et al., 2013).
In vitro studies have shown that ZnO is cytotoxic at relatively
low concentrations as compared to other types of engineered
nanomaterials such as titanium dioxide, carbon nanotubes
(Danielsen et al., 2014; Kermanizadeh et al., 2012, 2013a; Karlsson
et al., 2014). Similar ﬁndings on cytotoxicity have been observed in
broncho-alveolar lavage cells after pulmonary exposure to ZnO NP,
which has been attributed to the dissolution of Zn ions (Cho et al.,
2011; Kao et al., 2012). It has been shown that nanosized
(50e70 nm) and ﬁne (<1000 nm) ZnO particles elicited pulmonary
inﬂammation and cytotoxicity in rats after inhalation and intra-
tracheal exposure (Sayes et al., 2007; Warheit et al., 2009). Another
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study has shown that ZnO particles with primary sizes of 35 and
250 nm elicited a similar extent of pulmonary inﬂammation and
cytotoxicity in SpragueeDawley rats 24 h after a 6-hr inhalation
exposure (Ho et al., 2011). The available results suggest that the
dissolution of Zn ions is important for ZnO-mediated toxicity and
cell death (Landsiedel et al., 2014).
ZnO NP may be expected to be more toxic than larger ZnO
particles for several reasons; NP have a higher alveolar deposition
leading to prolonged retention. They can escape the lung and enter
the blood or lymphatic circulation. Their larger surface tomass ratio
of NP should lead to faster dissolution of ZnONP compared to larger
bulk sized ZnO particles. Moreover, whereas the uptake of particles
larger than 500 nm is restricted to specialized phagocytes, NPs are
also effectively absorbed by the ubiquitous endocytosis pathway.
By this way internalized NPs will enter the endo-lysosomal route,
where in consequence of the local acid environment, the intracel-
lular release of ions can signiﬁcantly be enhanced leading to the
important pathway of toxicity described as “lysosome-enhanced
Trojan horse effect” (Sabella et al., 2014).
Here we present three different studies on pulmonary exposure
to ZnO NP in mice. The investigations were conducted in different
laboratories, using different ZnO nanomaterials and different
mouse strains exposed via a fairly similar pulmonary exposure
technique (instillation or aspiration). These studies were prema-
turely terminated because the highest exposures were unexpect-
edly associated with severe toxicity or death. The purpose of the
present communication is to expand information on toxicological
data of ZnO nanomaterials up to acute and sub-acute effects of a
larger dose range.
2. Material and methods
2.1. Study #1
2.1.1. Mice and caging conditions
Female wild-type C57BL/6JBomTac (C57) mice aged 5e6 weeks
were obtained from Taconic (Ry, Denmark). The mice were
randomly divided into housing groups of 10 in polypropylene cages
(425 mm  266 mm  150 mm) with pinewood sawdust bedding
and enrichment in form of sticks of aspenwood and rodent tunnels
(Brogaarden, Denmark). The cageswere stored in roomswith a 12 h
light period from 6 a.m. to 6 p.m., and the temperature and relative
humidity in the animal room were 21 ± 2 C and 50 ± 5%, respec-
tively. The cages were sanitized on two occasions every week. All
mice were given free access to tap water and standard diet
(Altromin no. 1324, Altromin International, Lage, Germany). The
mice were kept under conventional animal facilities and were
allowed to acclimatize for 2e3 weeks before they entered the
experimental protocol (Saber et al., 2012a). All mice were 8 weeks
old at the time of the study, and the average weight at the day of
instillation was 18 ± 1.4 g. All animal procedures followed the
guidelines for the care and handling of laboratory animals ac-
cording to the EC Directive 86/609/EEC and the Danish law. The
Animal Experiment Inspectorate under the Danish Ministry of
Justice approved the study (2012-15-2934-00223).
2.1.1.1. Nanoparticles, characterization and preparation of suspen-
sions. The ZnO NP powder (CAS-No: 1314-13-2) (ZincoxTM 10, IBU-
tec advanced materials AG, Weimar, Germany) was produced by
pulsation reactor technique. According to the manufacturer the
Brunauer Emmett Teller (BET) surface area was 60 ± 5 m2/g, the
spherical particles had an average size of 12± 3 nm and a hexagonal
crystallographic phase. The purity was above 99% determined by
energy dispersive x-ray analysis. Characterization of the instillation
suspension by dynamic light scattering (DLS) Zetasizer nano ZS
(Malvern Inc., UK.) was performed as previously described
(Jacobsen et al., 2009). However, the refractive (Ri) and absorption
indices (Rs) was set at 2.020 and 0.400, respectively, the values for
ZnO NP. At concentrations between 0.04 and 0.36 mg/ml the ZnO
NP was present in a very similar narrow and clear peak with an
agglomerated number size between 59 and 68 nm. Reliable data
with a low polydispersity index (PDI) (between 0.21 and 0.29) was
obtained for the 3 low concentrations of ZnO NP. However, the high
dose used in the pilot experiment (3.24 mg/mL; 162 mg/animal)
yielded unreproducible, unreliable results likely caused by strong
agglomeration, sedimentation with decreasing count rates (Zeta
average size of 1e3 mm, PDI: 0.33e0.6).
The ZnO NP was suspended in 2% sibling mouse serum in MilliQ
water. The suspensions were sonicated as described in Poulsen
et al. (2015a) using a Branson Soniﬁer S-450D (Branson Ultra-
sonics Corp., Danbury, CT, USA) equipped with a disruptor horn
(model number 101-147-037 (Jackson et al., 2011a)). Total soni-
cation time was 16 min at an amplitude of 10%. Samples were
continuously cooled on ice during the sonication procedure. For the
pilot experiment a suspension of 3.24 mg/mL (162 mg/animal) was
prepared. Each instillation was 50 ml suspension followed by 150 ml
air. For the following study the high dose stock suspension was
prepared at 0.36 mg/mL (18 mg/animal). This suspension was
diluted 1:3 for the medium dose (0.12 mg/mL; 6 mg/animal) and
further 1:3 for the low dose (0.04 mg/mL; 2 mg/animal). Each of
these dilutions, were sonicated for 2 min. Vehicle control solutions
were prepared by sonicating 2% sibling mouse serum in MilliQ
water according to the full protocol.
2.1.1.2. Experimental design and exposure. Two mice were exposed
in a pilot study to 162 mg ZnO NP/animal. However, on the second
day these became visibly ill (immobile, pilo erection, hunched
posture) and the pilot experiment was terminated following
approximately 30 h. This was followed by the main study were
groups of mice were given 0, 2, 6 or 18 mg ZnO NP or 162 mg carbon
black Printex 90 by a single intratracheal instillation. Printex 90 is a
highly inﬂammatory particle that has been extensively examined
and used as a benchmark particle (Jacobsen et al., 2007, 2008, 2011;
Jackson et al., 2012; Bourdon et al., 2012; Hogsberg et al., 2013;
Vesterdal et al., 2010; Kyjovska et al., 2015a). Each exposed group
consisted of six mice (N¼ 6) and each control group of twelve mice
(N ¼ 12) and was planned to be killed after 1d and 3d. Additionally
eight unexposedmice were included in the study. A total of 80mice
were used in this study. An originally planned later time point for
termination was omitted due to high toxicity. The instillation
technique was performed as previously been described (Kyjovska
et al., 2015b). Brieﬂy, mice were anesthetized by inhalation of 4%
isoﬂurane, before being placed back down on a 50 sloped instil-
lation board. The tonguewas gently pushed aside. Using an external
cold light source (KL1500LED; Schott, Lyngby, Denmark), the tra-
chea could be visualized and intubated using a 24 gauge BD Insyte
catheter (Becton Dickinson, Denmark) with a shortened needle. The
correct location of each intubation catheter was tested using a
highly sensitive pressure transducer (pneumotachometer) devel-
oped at the National Research Centre for the Working Environment
in collaboration with John Frederiksen (FFE/P, Copenhagen,
Denmark). A 50 ml suspension was instilled followed by 200 ml air
with a 250 ml SGE glass syringe (250F-LT-GT, MicroLab, Aarhus,
Denmark). Control animals received vehicle instillations. All ani-
mals were gently downwards shaken three times to ensure that no
liquids were blocking the upper respiratory airways. After instilla-
tion, the mice wereweighed and transferred to the home cage until
termination.
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2.1.1.3. Blood, broncho-alveolar lavage ﬂuid, cells and preparation of
tissues. Mice were weighed at the day of instillation and again on
the day of dissection. The mice were anesthetized using Hypnorm®
(fentanyl citrate 0.315 mg/mL and ﬂuanisone 10 mg/mL from
Janssen Pharma) and Dormicum® (Midazolam 5 mg/mL from
Roche). Both anesthetics were mixed with equal volumes of sterile
water. A volume of 0.15 mL/25 g body weight was injected intra-
muscularly (half the dose per leg).
Preparation of broncho-alveolar lavage ﬂuid (BALF) was per-
formed as previously described (Poulsen et al., 2015b). Brieﬂy,
exsanguination was caused by withdrawal of blood from a heart
puncture. BALF and cells were obtained by infusing the lungs twice
with 1 mL sterile saline water per 25 g body weight. Each ﬂush
consisted of 3 slow up and downwards movements. The second
ﬂush was also performed with fresh saline water. The BALF was
stored on ice until centrifuged (400 g, 4 C, 10 min). The superna-
tant was divided in strips, snap-frozen in liquid-nitrogen and stored
at 80 C before quantiﬁcation of protein concentration (Pierce
BCA, BieeBerntsen, Denmark) according to the manufacturer's
description. The BALF cells were re-suspended in 100 mL medium
(HAMF12 with 10% fetal bovine serum). The cell suspension (40 mL)
was mixed with 160 mL medium containing 10% DMSO and stored
at 80 C for comet assay analysis which was performed as pre-
viously described (Saber et al., 2012b). For differential count 50 mL
cell suspension was collected on a microscope slide by centrifuga-
tion at 55 g, 4 min in a Cytofuge 2 (StatSpin, Bie and Berntsen,
Rødovre, Denmark). The slides were ﬁxed with 96% EtOH and
stained with May-Grünwald-Giemsa stain. The cellular composi-
tion of BALF cells was determined by scoring 200 cells. The total
number of cells was determined by using the NucleoCounter
(Chemometec, Allerød, Denmark) live/dead assay according to the
manufacturer's instructions.
Tissue samples of liver and lung were taken from two mice in
each of the three ZnO NP groups (2, 6 and 18 mg) as well as vehicle
controls. The samples were ﬁxed in neutral buffered formaldehyde
(4%), trimmed, parafﬁn-embedded and sections of 4e6 mm were
made and stained with hematoxylin and eosin for the histological
examination.
2.2. Study #2
2.2.1. Mice and caging conditions
Eight to twelve weeks old, female BALB/cAnNcrl mice were
obtained from Charles River Laboratories (Sulzfeld, Germany). The
animals were kept in isolated ventilated cages (IVC-Racks; BioZone,
Margate, UK), supplied with ﬁltered air and a 12-hr light/12-hr dark
cycle. Speciﬁc pathogen-free hygienic status was approved and
certiﬁed according to the Federation of European Laboratory Ani-
mal Science Associations guidelines (Nicklas et al., 2002). Standard
diet (Altromin no.1314, Altromin International, Lage, Germany) and
water were available ad libitum. Animals were 10e12 weeks of age
with body weights between 19.6 and 23.1 g at the beginning of the
study. Animal experiments were carried out according to the
German law of protection of animal life and were approved by an
external review committee for laboratory animal care. The approval
number for the speciﬁed studies was Az55 2-1-54-2531-115-05.
2.2.1.1. Nanoparticles, preparation and characterization of suspen-
sions. ZnO NP was obtained from Alfa Aesar (ID 43141, A Johnson
Matthey Company, Karlsruhe, Germany) with a nominal average
diameter of 70 nm. According to manufacturer the primary particle
size is: 24e71 nm; BET surface area: 15e45 m2/g, agglomerated.
The authors have previously determined the BET size to 13 m2/g
(Lenz et al., 2013). Crystalline silica (Min-U-Sil 5, a-quartz) was
obtained fromU.S. Silica Company, Berkerly Springs, WV, USA, with
a median diameter of 1.7 mm declared on the datasheet from the
manufacturer.
ZnO NP (5 and 15 mg in 50 ml suspension) and crystalline silica
(35 mg in 50ul suspension) was prepared in sterile, pyrogene-free
distilled water. Stock solutions (10 mg/mL) were sonicated using
a SonoPlus HD70 (Bachofer, Berlin, Germany) at a moderate energy
of 20W for 15 min prior to dilution. Each suspensionwas sonicated
for 10 min directly before use. According to our previous experi-
ence, the instillation of 50 mL distilled water did not cause any
measurable stress effects such as the expression of heat shock
protein hsp70/hsp1a (Stoeger et al., 2006). Unexposed control an-
imals were included as well as and sham exposed animals receiving
50 mL pure distilled water.
2.2.1.2. Experimental design and exposure. Controls and two dose
groups (5 and 15 mg/animal) were planned to be killed 24 h, 3 days,
or 7 days post-exposure. Each group consisted of 8 mice (N ¼ 8).
However, the experiment was terminated early for reasons of ani-
mal welfare (acute signiﬁcant weight loss) thus only 24 h post-
exposure were completed. A total of 40 mice were used for this
study.
Before instillation mice were anesthetized by intraperitoneal
injection of a mixture of xylazine (4.1 mg/kg body weight) and
ketamine (188.3 mg/kg body weight). The animals were then ﬁxed
in a supine position on a 60 incline board by holding their upper
incisor teeth. The tongue was gently extended using coated twee-
zers, and the mice were intubated through the mouth and trachea
using a bulb headed cannula inserted 10 mm into the trachea; a
suspension containing 5 or 15 mg particles, respectively, in 50 mL
pyrogene-free distilled water was instilled, followed by 100 mL air.
2.2.1.3. Blood, broncho-alveolar lavage ﬂuid and cells. Mice were
weighed at the day of instillation and again on the day of dissection.
They were anesthetized with an overdose of ketamine/xylazin (1%/
0.1%). Exsanguination was caused by retro-orbital collection of
500e700 ml of blood. The blood was collected in EDTA-coated tubes
and continuously rotated/moved prior to measurement by the
ADVIA 120 Hematology System (Siemens Healthcare Diagnostics,
Deerﬁeld, USA).
The lungs of the mice were lavaged 10 times with 1 mL of fresh
phosphate-buffered saline (PBS; 37 C), supplemented with com-
plete protease inhibitor cocktail (Roche Diagnostics, Mannheim,
Germany). BALF of each animal were pooled. Cytocentrifuged slides
were prepared by centrifugation (100 g, 5 min). BALF cells were
prepared for cell differentiation with May-Grünwald staining. Two
slides were prepared per animal and 2x 200 cells scored on each
slide.
Total protein and lactate dehydrogenase (LDH) as well as
secretion of 10 cytokines/chemokines were measured in cell-free
BALF. BALF was centrifuged at 1200 g, 15 min at 4 C. Total con-
centration of protein was determined using the Bradford method
and LDH concentration was determined by using Cytotoxicity
Detection Kit (Roche Applied Diagnostics, Germany). Levels of total
IgM were measured by ELISA using complementary capture and
detection antibody pairs as previously described (Beyerle et al.,
2011a). Cytokine release: Ten cytokines/chemokines were detec-
ted simultaneously in the BALF using Luminex technology (Linco
Research, St. Charles, MO). In this study, the secretions of the
following cytokines/chemokines were investigated: Interleukin
(IL)-1a, IL-6, IL-10, tumor necrosis factor (TNF)a, granulocyte-
colony stimulating factor (G-CSF), chemokine (C-X-C motif) ligand
(CXCL)1, CXCL-2, CXCL-5, CXCL-10, interferon (INF)g. The assay was
performed as described previously (Beyerle et al., 2011b). Monocyte
chemotactic protein (MCP)-1 also called chemokine (CeC motif)
ligand (CCL)2 was quantiﬁed in the BALF using mouse CCL-2/JE
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DuoSet ELISA (R&D Systems, Inc., Minneapolis, USA), according to
the manufacturer's instructions.
2.2.1.4. Oxidative stress parameters in lung tissue. Glutathione
(GSH), malondialdehyde (MDA) levels and catalase activity in the
lung tissue were determined by HPLC, as previously described
(Banerjee et al., 2009).
2.3. Study #3
2.3.1. Mice and caging conditions
Eight week-old C57BL/6N female mice were obtained from
Taconic Europe (Ry, Denmark). The animals were kept and housed
in positive-pressure air-conditioned units (25 C, 50% relative hu-
midity) on a 12:12-h light/dark cycle. All mice were given free ac-
cess to tap water and standard diet. The protocol of this
investigation was approved by the local ethical committee for an-
imal research. The laboratory approval number is LA1230312 and
the approval for the speciﬁed studies was 2010/UCL/MD/034.
2.3.1.1. Nanoparticles and preparation. The NM-111 (BASF Z-Cote;
Zincite ZnO NP functionalized with triethoxycaprylylsilane,
130 nm) was received from the European Commission Joint
Research Centre repository (JRC, Ispra, Italy). Nanomaterials were
sub-sampled and preserved under argon in the dark at room
temperature until use. The details on raw material characteristics
have been thoroughly examined previously within the same proj-
ect (Kermanizadeh et al., 2013b). X-ray diffraction (XRD) size:
58e93 nm. BET surface area: 18 m2/g. Via transmission electron
microscopy (TEM) the size morphology was shown to be diverse;
about 90% of particles with an aspect ratio of 1 were in the
20e200 nm size range and about 90% of particles with an aspect
ratio between 2 and 8.5 were in the 10e450 nm size range.
With the following exceptions the preparation of the suspen-
sions was identical as in study #1. The vehicle was composed of
0.5% EtOH (96%), 2% C57BL/6 mouse serum in MilliQ water. The
stock suspension was prepared at 2 mg/mL and it was sonicated on
ice (Virsonic 300 ultrasonic cell disrupter, Virtis, Gardiner, USA) for
16 min at an amplitude of 15%. The stock suspension was serially
diluted in the same dispersion media and sonicated for 15 min in a
water bath. Min-U-Sil was directly dispersed with the dispersion
medium (no sonication).
2.3.1.2. Experimental design and exposure. Mice received a single
pulmonary exposure dose of 12.5, 25, 50 and 100 mg ZnO NP/mouse
or vehicle/negative control (N ¼ 5). The positive control group
consisted of 8 mice and was exposed to crystalline silica (2.5 mg
Min-U-Sil/mouse; U.S. Silica Company, Berkeley Springs, USA),
known to induce an inﬂammatory and ﬁbrotic response. The
vehicle control animals were exposed to 0.5% EtOH (96%), 2%
C57BL/6 mouse serum in MilliQ water. The original experimental
plan was for the sacriﬁce of mice 2 months post-exposure.
The particles were administered in the lungs by pharyngeal
aspiration after 4% isoﬂurane for 30 s. NP suspensions at a ﬁxed
instillation volume of 50 ml, were deposited at the entrance of the
trachea utilizing a pipette. At the ﬁrst breath, the liquid was aero-
solized and aspirated into the lungs of the mice.
2.3.1.3. Broncho-alveolar lavage ﬂuid, cells and preparation of tissue.
Mice were sacriﬁced 2 months after instillationwith an overdose of
sodium pentobarbital (15mg/mouse intraperitoneally). Lungs were
lavaged by the cannulation of the trachea and ﬂushing lobes with
1 mL NaCl 0.9%. The lavage ﬂuid was centrifuged (200 g, 10 min,
4 C) and the cell-free supernatant was used for the measurement
of LDH activity, protein content and quantiﬁcation of selected cy-
tokines. The measurement of LDH activity was performed using a
Synchron LX Unicell DXC-800 (Beckman Coulter, Brea, USA) in the
presence of 11 mM of NADþ and 50 mM lactate. The total protein
concentration was quantiﬁed spectrophotometrically at 600 nm
after complexationwith molybdate pyrogallol red. Finally, enzyme-
linked immunosorbent assays (ELISA) were performed according to
manufacturer's instructions (R&D Systems, Minneapolis, USA):
TNFa, IL-1 a, IL-1 b, IL-6, IL-13, active transforming growth factor
(TGF)-b1 and osteopontin (OPN) also called secreted phosphopro-
tein 1 (SPP-1).
The cell pellets were resuspended in NaCl 0.9%. BALF total cell
number for each animal was determined in Turch (1% crystal violet
(Merck, Darmstadt, Germany), 3% acetic acid). Cells were also pel-
leted onto glass slides by cytocentrifugation for differentiation by
light microscopy after Diff-Quick staining (200 cells counted, Dade
Behring AG, Düdingen, Switzerland).
Total pulmonary collagen was determined via OH-proline, an
amino acid relatively speciﬁc for, and a major component of
collagen. Following lavage, lungs were perfused with NaCl 0.9%,
excised and placed in 3 mL ice-cold PBS. They were then homog-
enized on ice with an Ultra-Turrax T25 homogenizer (Janke &
Kunkel, Brussels, Belgium) and stored at 80 C. Part of the lung
homogenate was hydrolyzed in HCl 6N at 108 C during 24 h and
OH-proline was quantiﬁed by high-performance liquid chroma-
tography (Biondi et al., 1997).
Table 1
Body weight (g) of vehicle control mice and mice exposed to ZnO nanoparticles or Printex 90 at day of instillation (Day 0) and 2 and 3 days post-exposure.
Instillation Weight Termination Weight D Weight # Of mice
Control Day 0 17.2 ± 0.3 Day 1 ND 12
ZnO 2 mg 17.8 ± 0.5 ND 6
ZnO 6 mg 18.3 ± 0.5 ND 6
ZnO 18 mg 17.8 ± 0.8 ND 6
P90 162 mg 17.6 ± 0.2 ND 6
Control Day 0 18.5 ± 0.8 Day 2 19.2 ± 0.9 þ0.7 g 2
ZnO 2 mg 17.2 ± 0.0 17.3 ± 0.0 þ0.2 g 2
ZnO 6 mg 19.0 ± 0.5 17.0 ± 0.0  2.0 g* 2
ZnO 18 mg 18.2 ± 0.7 15.6 ± 0.7  2.6 g* 6
Control Day 0 18.8 ± 0.5 Day 3 19.0 ± 0.5 þ0.3 g 10
ZnO 2 mg 17.3 ± 0.7 17.5 ± 0.7 þ0.2 g 4
ZnO 6 mg 18.3 ± 0.7 16.1 ± 0.7  2.2 g* 4
ZnO 18 mg e e e e
P90 162 mg 18.1 ± 0.4 18.4 ± 0.4 þ0.3 g 6
Average weight of all 72 mice at the day of instillation 18 ± 1.3 g.
Results are given as mean ± SEM. P90; Printex 90 carbon black. ND: Not determined. Asterisks refer to statistical signiﬁcance *p < 0.05 when comparing to the relevant vehicle
control.
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2.3.1.4. Statistical analysis for all 3 studies. All data are presented as
mean values ± standard error of the mean (SEM). Differences were
evaluated by using one-way analysis of variance followed by Sidak's
test. Blood parameters (study 2) were analyzed by general linear
model (GLM) followed by Sidak's test. Certain endpoints within
study 2; macrophages, lymphocytes, neutrophils, CXCL-1, IL-6,
CXCL-10 CXCL-5, G-CSF, MDA, Protein and LDH, and within study 3;
total BAL cells, macrophages, lymphocytes and neutrophils dis-
played inhomogeneity of variance (p < 0.05, Bartlett's test). The
statistical signiﬁcance was conﬁrmed using KruskaleWallis non-
parametric test, whereas we have reported P-values of Sidak's
tests for consistency in the manuscript. The mortality data was
analyzed by c2. All statistical analysis was performed using STATA
13 (STATACORP LP, College station TX, USA) except for blood pa-
rameters which were analyzed usingMiniTab 17 (Minitab Inc., State
College, PA, USA).
3. Results
3.1. Study #1
The pilot study (2 mice, 162 mg ZnO NP) was terminated after
about 30 h as the mice showed complete immobility and breathing
difﬁculty. At autopsy it was shown that their lungs were ﬁlled with
blood.
3.1.1. Body weight of mice
The weight of all mice was recorded immediately before the
exposure and again at the termination day 2 and 3 (but not day 1).
Table 2
The cellular distribution in broncho-alveolar lavage ﬂuid.
Dose (mg) Total # Macrophages Lymphocytes Neutrophils Eosinophils Epithelial
1 day
ZnO
0 97,750 ± 12,177 75,430 ± 11,048 1104 ± 435 5349 ± 1155 715 ± 301 15,153 ± 2063
2 77,500 ± 6168 43,298 ± 3178 1118 ± 535 21,780 ± 2650 1663 ± 546 9643 ± 2176
6 80,500 ± 5277 34,078 ± 4437 848 ± 192 21,900 ± 4312 1238 ± 487 22,428 ± 3950
18 94,000 ± 11,790 35,140 ± 7899 438 ± 206 35,083 ± 10516 188 ± 127 23,153 ± 3434
P90 162 259,500 ± 27,086 27,803 ± 6113 1750 ± 1051 187,738 ± 16,959*** 23,373 ± 9098 18,838 ± 6590
3 day
ZnO
0 87,600 ± 7332 72,090 ± 5931 1301 ± 441 582 ± 224 2621 ± 887 11,007 ± 1843
2 166,500 ± 42,294 121,556 ± 30,145 1436 ± 942 16,046 ± 2630 4991 ± 3563 17,126 ± 2818
6 454,500 ± 67,043*** 12,7714 ± 28,954 15,105 ± 11,731** 271,170 ± 66,056*** 7545 ± 3134 32,966 ± 12,220**
18 e e e e e e
P90 162 222,500 ± 40,572*** 69,338 ± 16,349 4180 ± 1562 76,930 ± 11,898** 56,983 ± 27,913*** 15,070 ± 3278
Unexposed 67,125 ± 8017 57,602 ± 8194* 585 ± 192 746 ± 342 32 ± 32 8160 ± 713
All cells are listed in actual numbers. Results are given as mean ± SEM. P90; Printex 90 carbon black. ND: Not determined (terminated due to animal suffering). Asterisks refer
to statistical signiﬁcance **p < 0.01 and ***p < 0.001 when comparing to the relevant vehicle control. All samples were scored randomized.
Table 3
Red blood cells and concentration of protein in broncho-alveolar lavage ﬂuid and
DNA damage by the comet assay in the lavaged cells.
Dose
(mg)
RBC Protein Comet assay # Animals
1 day
ZnO
0 0.5 312 ± 21 7.4 ± 0.9 12
2 0.8 522 ± 58 11.8 ± 1.6 6
6 1.0 659 ± 76 13.4 ± 1.3* 6
18 1.2 626 ± 91 14.9 ± 1.7*** 6
P90 162 0.6 ND 8.2 ± 1.1 6
3 day
ZnO
0 0.6 301 ± 34 9.2 ± 0.7 10
2 0.3 574 ± 158 7.7 ± 0.8 4
6 2.3*** 4591 ± 1083*** 6.8 ± 0.4 4
18 e e e e
P90 162 0.2 ND 12.6 ± 1.5 6
Unexposed 0.1 235 ± 20 8.1 ± 1.0 8
Results are given as mean or mean ± SEM. P90; Printex 90 carbon black. Not
determined (terminated due to animal suffering). Asterisks refer to statistical sig-
niﬁcance *p < 0.05 and ***p < 0.001 when comparing to the relevant vehicle control.
Red blood cells (RBC) were scored on a 4 tier scale (0e3): 0; non to very few RCB, 1;
some RBC and 2; high levels of RBC and 3; very high levels of RBC. Proteins are
presented as mg/ml. Comet as %Tail DNA. All samples were coded before analysis.
Table 4
Type and incidence of histopathological changes in lungs and livers from mice 2 days post a single exposure of ZnO nanoparticles by intratracheal instillation.
Organ Type of lesion Control Nano ZnO
2 mg 6 mg 18 mg
Lungs Lymphoid cell inﬁltration of
alveolar lamina 0/2 1/2 1/2 0/2
alveolar walls 0/2 0/2 2/2 0/2
interstitium 0/2 1/2 1/2 1/2
Excessive desquamation of bronchiole epithelium 0/2 2/2 1/2 2/2
Hypertrophy of epithelial cells of bronchioles 0/2 2/2 0/2 2/2
Proliferation of epithelial cells of bronchioles 0/2 0/2 1/2 0/2
Oedema
alveolar walls 0/2 0/2 2/2 0/2
subepithelial 0/2 0/2 1/2 0/2
interstitial 0/2 0/2 0/2 1/1
perivascular 0/2 0/2 0/2 2/2
Congestion 2/2 2/2 2/2 2/2
Liver Increased number of binucleate hepatocytesa 0/2 2/2 2/2 2/2
Enlargement of single hepatocytes (hypertrophy) 0/2 1/2 1/2 2/2
Necrosis of single hepatocytes 0/2 1/2 0/2 1/2
Inﬂammatory cell focus 0/2 1/2 0/2 0/2
Vacuolization of cytoplasm of hepatocytes (midzonal) 2/2 2/2 2/2 2/2
Congestion 2/2 1/2 1/2 2/2
a Qualitative evaluation only.
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The body weight signiﬁcantly decreased by 14% at 2 days post-
exposure in the group of mice that received 18 mg ZnO NP
(Table 1). A decrease in body weight was also observed for mice
exposed to 6 mg. Their weight signiﬁcantly decreased by 11 and 12%
at day 2 and 3 post-exposure, respectively. A marginal increase
(between 0.9 and 3.8%) in body weight was observed for vehicle,
2 mg ZnO NP and Printex 90 exposed mice.
3.1.2. BALF: cellular composition, proteins and comet assay
The number and composition of cells in the lung lumen was
assessed by NucleoCounter andmicroscopy (Table 2). One day post-
exposure the results show a reduction in macrophages and an in-
crease in neutrophils. However, three days post-exposure total cell
numbers increased 2e5-fold for 2 and 6 mg exposures, respectively.
This was mainly driven by a doubling of macrophages and a very
Fig. 1. Morphological patterns of the lung (AeD) and liver (EeH) in mice 2 days after intratracheal instillation of ZnO NP. A, E illustrate the normal structures in control animals.
Slight vacuolization of hepatocyte cytoplasm (white spaces). B, F emice exposed to 2 mg ZnO NP: desquamation (d) of the bronchiole epithelium, numerous binucleate hepatocytes
(arrows); C, G emice exposed to 6 mg ZnO NP: congestion (c), oedema (asterisks), numerous binucleate hepatocytes (arrows), slightly visible vacuolization of hepatocyte cytoplasm
(white spaces), enlargement of hepatocytes (head of arrows); D, H e mice exposed to 18 mg ZnO NP: extensive interstitial oedema (asterisks), desquamation of the bronchiole
epithelium (d), congestion (c), inﬁltration of lymphoid cells (short arrows), numerous binucleate hepatocytes (long arrows), enlargement of hepatocytes (head of arrows), intensive
vacuolization of hepatocyte cytoplasm (white spaces), necrosis of the singles hepatocytes (in the circles). HE staining, magniﬁcations were the same for all images as shown on
image H.
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large increase in neutrophils (30 to 511-fold for 2 and 6 mg expo-
sures, respectively). In addition to these large increases in macro-
phages and neutrophils, 6 mg exposedmice also showed an increase
in lymphocytes (3-foldw/o,12-fold with a high outlier) (Table 2). As
these mice also displayed very high numbers of red blood cells in
the BALF, these results indicate alveolar-capillary barrier damage
with loss of membrane integrity (Table 3). This was further sup-
ported by the 15-fold increase in concentration of BALF proteins
indicating cellular damage aswell as serum protein leaking through
the disrupted alveolar-capillary barrier into the pulmonary space.
This is strongly exempliﬁed by the steep increase in red blood cells
present in the BALF and on the cytoslides from animals exposed to
6 mg ZnO NP 3 days post-exposure (p < 0.001).
Comet assay was used to determine possible DNA damage
(strand breaks) in the BALF cells. The results indicate a dose
dependent increase (1.6, 1.8 and 2-fold) for ZnO NP exposed mice
one day post-exposure. However, three days post-exposure this
was reduced to a marginal decrease in genotoxicity (Table 3).
3.1.3. Lung and liver histology by light microscopy
As mice exposed to 18 mg ZnO NP manifested severe clinical
signs of toxicity (recumbency, immobility, pilo erection) 2 days
post-exposure, it was decided to terminate this group (off schedule)
and to perform a histopathological examination of lungs and liver
from two mice in each of the groups 0, 2, and 6 mg ZnO NP/mouse.
The rest of the mice were terminated as scheduled three days after
exposure). Histological results are summarized in Table 4. As the
animals were not exsanguinated, congestion was observed in all
samples from lungs and livers.
An excessive desquamation of epithelial cells of bronchioles as
compared to the controls was recorded in all but one ZnO NP
exposed animals; the severity of the lesion varied between the
treated animals without a clear dose response. Other changes
indicative of pulmonary injury were oedema (perivascular, sub-
epitelial, interstitial and/or of alveolar walls) in animals from mid
and high ZnO NP dose groups, lymphoid cell inﬁltration of the
interstitial tissue or in alveolar interstitium or lamina, and hyper-
trophy of single epithelial cells or proliferation of epithelial cells of
bronchioles were recorded occasionally (Table 4).
In the livers from ZnO NP exposed animals the most noteworthy
changes were an increased presence of binucleate hepatocytes and
enlargement of single hepatocyte. Both these lesions are consid-
ered as indicative of a regenerative activity of liver tissue after
exposure to a toxicant (Kostka et al., 2000). Mice exposed to 2 and
18 mg ZnO NP had necrosis of single hepatocytes. The number of
recorded pathomorphological changes was similar in animals
exposed to ZnO NP, however the changes appeared more severe in
the animas exposed to 18 mg ZnO NP. Exempliﬁed images of lung
and livers from all exposure groups are shown in Fig. 1.
3.2. Study #2
3.2.1. Weight of mice
The experiment was stopped 24 h after exposure due to signs of
distress and acute toxicity (reduced body weight, reduced mobility
and pilo erection) in the 15 mg ZnO NP group. Body weight was
determined on day of application and on day of dissection. Body
weight loss was calculated as the difference between the day of
dissection and the day of instillation. At 24 h the 15 mg ZnO NP
group had an 11% reduced body weight (p < 0.001), whereas all
other groups showed a marginal weight reduction of 4e5%
(Table 5). This is a clear sign of acute poisoning in the high dose ZnO
NP group.
3.2.2. Blood parameters
Systemic effects were determined via a hematological analysis
of 45 parameters. The GLM ANOVA showed signiﬁcant difference
for 32 of the 45 blood parameters. The 32 parameters were tested
post hoc and the high dose zinc group showed signiﬁcant
Table 5
Body weight and selected blood parameters.
1 Day Dose (mg) Body weight WBC Neutrophils Lympho Platelets L-Platelets Hematocrit RBC
ZnO 0 3.8 ± 0.7 7.3 ± 0.4 0.9 ± 0.1 6.1 ± 0.3 1072 ± 23 3.6 ± 0.8 49.7 ± 0.5 10.2 ± 0.1
5 5.2 ± 0.9 4.7 ± 0.5*** 0.8 ± 0.1 3.7 ± 0.4*** 979 ± 32 8.0 ± 1.1 50.2 ± 0.6 10.1 ± 0.1
15 11.0 ± 1.1*** 4.3 ± 0.6*** 1.9 ± 0.4*** 2.3 ± 0.3*** 1210 ± 58* 11.0 ± 2.9** 54.3 ± 2.2* 11.0 ± 0.4*
SiO2 35 3.8 ± 0.6 5.2 ± 0.3** 0.9 ± 0.1 4.1 ± 0.3*** 1008 ± 39 6.3 ± 1.6 49.9 ± 0.6 10.2 ± 0.1
Unexposed 4.4 ± 0.4 6.0 ± 0.4 0.8 ± 0.1 4.9 ± 0.3* 997 ± 24 2.4 ± 0.6 48.0 ± 0.5 9.8 ± 0.1
Body weights are listed as % reduction in body weight as compared to weight on the day of instillation. WBC (White blood cells), Neutrophils, Lympho (lymphocytes), Platelets,
L-Platelets (large platelets) are listed in actual numbers (103/ml blood). Hematocrit is in %. RBC (red blood cells  106/ml blood). Results are given as mean ± SEM. SiO2 is
crystalline silica Min-U-Sil 5. Asterisks refer to statistical signiﬁcance *p < 0.05, **p < 0.01 and ***p < 0.001 when comparing to the vehicle control (N ¼ 8).
Table 6
The cellular distribution in broncho-alveolar lavage ﬂuid.
1 Day Dose (mg) Total # Macrophages Lymphocytes Neutrophils
ZnO 0 456,000 ± 33,000 423,000 ± 90,000 1800 ± 2200 31,300 ± 6800
5 369,000 ± 32,000 321,000 ± 64,000 4200 ± 3100 43,900 ± 28,500
15 523,000 ± 78000 233,000 ± 52,000* 10,100 ± 6000*** 280,100 ± 175,200***
SiO2 35 488,000 ± 49,000 293,000 ± 77,000 3000 ± 1400 192,100 ± 70,300**
Unexposed 486,000 ± 49,000 482,000 ± 143,000 0 ± 0 3700 ± 3500
All cells are listed in actual numbers. Results are given as mean ± SEM. SiO2 is crystalline silica Min-U-Sil 5. Asterisks refer to statistical signiﬁcance *p < 0.05, **p < 0.01 and
***p < 0.001 when comparing to the vehicle control (N ¼ 8).
Table 7
Markers of tissue damage determined broncho-alveolar lavage ﬂuid.
1 Day Dose (mg) LDH Protein IgM
ZnO 0 22.4 ± 7.5 138 ± 14 5.0 ± 1.3
5 58.4 ± 13.0 148 ± 16 18.2 ± 9.2
15 637.1 ± 95.2*** 447 ± 30*** 178.9 ± 6.9***
SiO2 35 166.2 ± 36.1 138 ± 13 28.3 ± 8.7
Unexposed 28.6 ± 8.1 105 ± 5 14.0 ± 3.3
Results are given as mean ± SEM. SiO2 is crystalline silica Min-U-Sil 5. LDH (Lactate
dehydrogenase U/ml). Proteins (mg/ml). IgM (Immunoglobulin M pg/ml). Asterisks
refer to statistical signiﬁcance *p < 0.05, **p < 0.01 and ***p < 0.001 when
comparing to the vehicle control (N ¼ 8).
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difference in 28 of these parameters. The low dose zinc group
showed signiﬁcant difference in 11 parameters, whereas SiO2 and
unexposed controls showed signiﬁcant difference in 6 and 1
parameter, respectively. Selected parameters are shown in Table 5.
A strong increase in neutrophils and a reduction in white blood
cells and lymphocytes was observed for the 15 mg ZnO NP group as
compared to vehicle control. Increased number of blood neutro-
phils is a clear sign for an acute systemic inﬂammatory response to
the pulmonary injury caused by ZnO. The increase in neutrophils
might be on the expense of lymphocytes which present the ma-
jority of white blood cells in mice (Table 5). This combined with a
possible retention of activated leukocytes in the injured capillary
bed of the lungs cause a temporal lymphopenia.
Acute inﬂammation is often accompanied by increased platelet
production, resulting in increased platelet counts and enhanced
blood coagulability. The presence of immature, large platelets and
clumbs of activated platelets are the hematological signs observed
during the acute phase of systemic inﬂammation. Platelet count
(p < 0.05), large platelets (p < 0.01) and clumps count (p < 0.05; not
shown) were all signiﬁcant elevated in the 15 mg ZnO NP group
indicating thrombocytosis/thrombocythemia (Table 5). No other
group showed any statistically signiﬁcant altered platelet status,
although the low dose ZnO NP showed a marginal increase in large
platelets.
Increased production of red blood cells (polycythemia) and
raised hematocrit (Table 5) may be assumed as further systemic
signs to pulmonary injury, as the body compensates insufﬁcient
oxygen absorption by producing more red blood cells.
3.2.3. BALF: cellular composition, LDH, protein, immunoglobulin M
and cytokines
Cellular composition was determined by microscopy. A very
strong pulmonary inﬂux (9-fold) of neutrophils was observed in the
15 mg group 24 h post-exposure, accompanied by a reduction of
macrophages to about half. There was no increase in neutrophils
and only amarginal reduction inmacrophageswas observed for the
5 mg group (Table 6).
ZnO NP (15 mg) caused signiﬁcant toxicity to lung. This was
Table 8
Cytokines assessed in broncho-alveolar lavage ﬂuid.
1 Day Dose (mg) IL-6 CXCL-1 CXCL-10 CCL-2 G-CSF
ZnO 0 2.8 ± 0.0 27.3 ± 14.4 8.9 ± 4.7 5.6 ± 0.9 6.6 ± 1.1
5 4.7 ± 3.3 25.3 ± 9.6 6.2 ± 0.0 10.5 ± 2.0 9.0 ± 7.1
15 1356.1 ± 990.6** 349.9 ± 183.8*** 108.3 ± 34.1*** 37.3 ± 2.1*** 1933.4 ± 374.2***
SiO2 35 1.8 ± 1.0 175.9 ± 32.7 11.9 ± 8.8 11.1 ± 1.5 47.5 ± 8.3
Unexposed 2.8 ± 0.0 14.8 ± 2.5 5.5 ± 1.6 9.2 ± 1.5 3.5 ± 0.9
1 Day Dose (mg) TNFa IL-1a IL-10 CXCL-5 IFNg
ZnO 0 0.8 ± 0.6 50.6 ± 10.0 38.7 ± 16.9 2.5 ± 0.0 9.2 ± 6.8
5 1.2 ± 0.7 29.0 ± 10.3 10.6 ± 6.4 3.1 ± 1.0 3.8 ± 0.0
15 2.4 ± 1.2 56.8 ± 9.4 46.2 ± 33.1 5.1 ± 4.5 12.0 ± 1.0
SiO2 35 5.5 ± 1.5*** 57.4 ± 11.7 26.7 ± 19.8 36.4 ± 11.1** 8.1 ± 6.7
Unexposed 1.1 ± 0.4 63.9 ± 5.6 35.1 ± 18.9 8.6 ± 7.7 9.8 ± 5.6
Results are given asmean ± SEM. SiO2 is crystalline silica Min-U-Sil 5. All cytokines (pg/ml). Asterisks refer to statistical signiﬁcance *p < 0.05, **p < 0.01 and ***p < 0.001when
comparing to the vehicle control (N ¼ 8).
Table 9
Oxidative stress parameters determined in lung tissue.
1 Day Dose (mg) GSH MDA Catalase
ZnO 0 16.6 ± 0.7 16.7 ± 0.3 13.9 ± 0.5
5 16.1 ± 0.6 17.5 ± 1.0 17.6 ± 0.4***
15 12.4 ± 0.5*** 30.4 ± 0.9*** 13.2 ± 0.5
SiO2 35 14.0 ± 0.4* 18.4 ± 0.8* 14.5 ± 0.2
Unexposed 15.8 ± 0.4 14.4 ± 0.4 14.4 ± 0.2
Results are given as mean ± SEM. SiO2 is crystalline silica Min-U-Sil 5. GSH; gluta-
thione (nmol/mg protein). MDA; malondialdehyde (nmol/100 mg protein). Catalase
(U/mg protein). Asterisks refer to statistical signiﬁcance *p < 0.05, **p < 0.01 and
***p < 0.001 when comparing to the vehicle control (N ¼ 8).
Fig. 2. Mortality curve for mice exposed to nanosized ZnO (N ¼ 5).
Table 10
Cellular distribution in broncho-alveolar lavage ﬂuid.
2 Months Dose (mg) Total # Macrophages Lymphocytes Neutrophils Eosinophils
ZnO 0 48,300 ± 14,181 34,235 ± 6089 7376 ± 3804 163 ± 94 6526 ± 4457
12.5 49,400 ± 13,917 48,710 ± 13,828 499 ± 185 190 ± 101 0
25 75,833 ± 16,220 72,857 ± 17,459 2975 ± 1291 0 0
50 44,750 ± 9750 43,582 ± 9282 1031 ± 331 0 0
SiO2 0 26,571 ± 2438 22,148 ± 2217 2450 ± 635 182 ± 71 1790 ± 671
2500 80,062 ± 14,228* 54,237 ± 10,878 14,934 ± 3384* 9865 ± 1874*** 1221 ± 497
All cells are listed in actual numbers. Results are given as mean ± SEM. SiO2 is crystalline silica Min-U-Sil. Asterisks refer to statistical signiﬁcance *p < 0.05 and ***p < 0.001
when comparing to the relevant vehicle control. Only animals that survived 2 months post-exposure was included. ZnP NP groups 0 and 12.5 mg (N ¼ 5), ZnP NP group 25 mg
(N ¼ 3), ZnP NP group 50 mg (N ¼ 2) and SiO2 groups 0 and 2500 mg (N ¼ 8).
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illustrated by a strong increase in LDH (28-fold, p < 0.001) caused
by cell and tissue damage. Additionally, increased epithelial-
endothelial permeability and cell leakage was shown by elevated
concentration of BALF proteins (3-fold; p < 0.001). There was a 36-
fold (p < 0.001) increase in Immunoglobulin M (IgM) in BALF 24 h
post-exposure in the high dose group. IgM is the largest antibody in
the bloodstream and the ﬁrst antibody to appear in response to
initial antigen exposure. IgM accumulation in BALF may indicate an
injury to the alveolar barrier allowing the leakage of large serum
proteins into the alveolar space (IgM is 970 kDa). Only minor dif-
ferences were observed for the low dose group (5 mg) (Table 7).
Overall, treatment with 15 mg of ZnO NP caused a dramatic in-
crease in expression of pro-inﬂammatory cytokine IL-6 (484-fold)
as well as chemotactic cytokines such as CXCL-1 (KC) and CCL-2
(MCP-1) involved in the recruitment of neutrophils and mono-
cytes/macrophages, respectively, to the site of inﬂammation. The
latter two increased by 13- and 7-fold, respectively. Additionally, G-
CSF and CXCL-10 which also may be involved in maintaining pul-
monary inﬂammation, enhancing granulocyte survival and attrac-
tion of monocytes/macrophages and T cells were signiﬁcantly
elevated 293- and 12-fold, respectively. Elevated levels of CCL-2
and CXCL-10 have been associated with pulmonary ﬁbrosis,
although CCL-2 is a known ﬁbrocyte chemoattractant (Murray
et al., 2008), exogenous CXCL-10 inhibited ﬁbrogenesis (Jiang
et al., 2010). CCL-2 may promote fibrogenesis whereas CXCL-10
may act antifibrogenic. Finally, no signiﬁcant changes in expres-
sion of TNFa, IL-1a and the anti-inﬂammatory cytokine IL-10, CXCL-
5 and IFNg were observed for any of the groups (Table 8).
3.2.4. Oxidative stress in lung tissue
Oxidative stress markers assessed in lung tissue, reﬂected
depletion of the antioxidant glutathione (GSH), levels of the lipid
peroxidation product malondialdehyde (MDA), and activity of the
antioxidant enzyme catalase. For the high dose ZnO NP (15 mg) a
signiﬁcant decrease in GSH accompanied by a signiﬁcant increase
in MDA levels was observed, while, catalase activity was unaltered.
The 5 mg group showed the opposite with no change in GSH and
MDA but with a signiﬁcant increase in catalase activity (Table 9).
3.3. Study #3
3.3.1. Mortality
Mice were exposed once to NM-111 ZnO NP by oro-pharyngeal
aspiration. Animal mortality was observed for some doses. All 5
mice in the 100 mg/mouse group and 3 mice in the 50 mg/mouse
group died within 5 days post-exposure. Two mice in the 25 mg/
mouse group died within 13 days post-exposure. None of the mice
in the 12.5 mg/mouse, negative control or positive control (crys-
talline silica) groups died prior to scheduled termination (Fig. 2).
There was a strong association between ZnO NP dose and mortality
(p < 0.01; c2 ¼ 15).
3.3.2. BALF: cellular composition, LDH, proteins and cytokines
Only animals that survived 2 months post-exposure were
included in these analyses. This weakens the statistical power. The
number and composition of cells in the BALF was not signiﬁcantly
changed for any of the ZnO NP exposure groups 2 months post-
exposure (Table 10). There was a small increase of macrophages,
but almost no neutrophils, lymphocytes or eosinophils were pre-
sent. The 25 mg group showed marginally higher levels of some cell
types. However, the % distribution of these cell types was almost
identical to the other ZnO NP groups.
The integrity of pulmonary cells and the alveolar-capillary
membrane barrier was evaluated via LDH activity and total pro-
tein levels in the BALF. However, ZnO NP had no effect on these
parameters two months post-exposure in the surviving animals
(Table 11).
Cytokines and growth factors were assessed in BALF by ELISA.
ZnO NP had no signiﬁcant effect on the pro-inﬂammatory cytokines
IL-1a, IL-1b, TNFa and IL-6, the pro-ﬁbrotic TGF- b1 or the cytokines
IL-13 and OPN, in surviving animals. All protein levels were similar
or marginally lowered compared to vehicle control exposed mice
(Table 11).
3.3.3. Pulmonary ﬁbrosis
A potential ﬁbrotic response was assessed via the hydroxypro-
line lung content, a marker for collagen accumulation. ZnO NP
induced a marginal (low doses) and signiﬁcant (50 mg) induction of
collagen. However, although signiﬁcant for high dose group, it
should be noted that 3 mice died shortly after intratracheal instil-
lation in this group. Thus only 2 mice are represented in the 50 mg
group 2months post-exposure. The fold increase in hydroxyproline
was similar for 50 mg ZnO NP and 2500 mg SiO2 (1.4 and 1.5-fold,
respectively) (Table 11).
4. Discussion
NP are mobile, easily inhaled and can deposit in the pulmonary
alveoli at a much higher frequency than larger bulk sized particles.
Although literature on hazards related to inhalation of nanosized
Table 11
LDH, concentration of proteins, cytokines assessed in broncho-alveolar lavage ﬂuid and hydroxyproline in lung tissue.
2 Months Dose (mg) LDH Protein IL-1b IL-1a IL-6
ZnO 0 54 ± 2.2 74 ± 8 5.0 ± 1.0 21.5 ± 5.5 16.6 ± 2.7
12.5 56 ± 7.0 60 ± 5 3.7 ± 0.4 23.0 ± 3.1 13.7 ± 1.1
25 47 ± 9.2 60 ± 6 3.5 ± 0.1 16.5 ± 1.1 11.8 ± 1.2
50 41 ± 0.0 65 ± 5 3.5 ± 0.3 15.0 ± 0.2 11.6 ± 0.0
SiO2 0 62 ± 10.2 54 ± 9 4.9 ± 2.3 22.6 ± 1.6 18.6 ± 1.6
2500 130.4 ± 14.3** 155 ± 12*** 4.5 ± 0.3 19.4 ± 1.2 19.6 ± 1.5
2 months Dose (mg) TNFa IL-13 TGF-b1 OPN OH-Proline
ZnO 0 29.7 ± 7.7 6.0 ± 3.4 47.3 ± 11.6 20,999 ± 5392 254 ± 14
12.5 43.1 ± 11.6 2.5 ± 0.6 40.8 ± 4.5 11,508 ± 917 259 ± 20
25 13.5 ± 1.1 1.5 ± 0.0 32.9 ± 4.1 10,963 ± 699 276 ± 7
50 24.8 ± 3.4 1.6 ± 0.0 55.9 ± 10 16,624 ± 1644 363 ± 54*
SiO2 0 59.3 ± 13.4 5.2 ± 1.2 52.3 ± 6.0 16,372 ± 2197 191 ± 23
2500 26.2 ± 5.8 4.6 ± 0.3 80.4 ± 14.4 76,201 ± 8450 281 ± 12**
Results are given as mean ± SEM. SiO2 is crystalline silica Min-U-Sil. LDH (U/l); Protein (mg/ml); Cytokines (pg/ml). Asterisks refer to statistical signiﬁcance *p < 0.05, **p < 0.01
and ***p < 0.001 when comparing to the relevant vehicle control. Only animals that survived 2 months post-exposure was included. ZnP NP groups 0 and 12.5 mg (N ¼ 5), ZnP
NP group 25 mg (N ¼ 3), ZnP NP group 50 mg (N ¼ 2) and SiO2 groups 0 and 2500 mg (N ¼ 8).
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ZnO is available, information on lung toxicity is still limited and the
doses used are primarily low. Here we present results from three
experiments that each investigate the acute or sub-acute pulmo-
nary toxicity of nanosized ZnO. The pulmonary toxicity is charac-
terized by oxidative stress, inﬂammation, genotoxicity and cell
death. Doses used in the present publication spanned from 2 to
100 mg/mouse (162 mg in the pilot study).
The most pronounced effect observed following the ZnO NP
exposure was the clear association between exposure dose and
mortality (Study 3). A mortality rate of 40% was observed at a bolus
dose of 25 mg (~1.4 mg/kg mouse body weight) and increasing to
100% at a dose of 100 mg. Mortality caused by pulmonary exposure
to ZnO particles has to the best of our knowledge not been reported
previously in the literature. The currently available reports on ZnO
toxicity in animal models have used sub-lethal doses, too short
post-exposure time, or moribund/dead animals have not been
included in the biochemical and histopathological examinations.
However, LD50 for ZnO NP was calculated to be 0.3 mg/kg in
intravenously exposed ICR mice (Fujihara et al., 2015). Also mor-
tality has been reported following high peritoneal exposure
(80 mg/kg body weight) of ZnO  200 nm in rats (Landsiedel et al.,
2010) and a high oral NP exposure inmice (333mg/kg bodyweight)
(Esmaeillou et al., 2013). The highest pulmonary exposure dose
found in the literature is 50 mg instilled in guinea pigs (222 mg/kg
guinea pig body weight). Although, these particles were very large
(<5000 nm) leading to a slow dissolution of Zn(II), species speciﬁc
differences in the toxic response cannot be excluded (Gupta et al.,
1986). Also no mortality or reduced body weight was observed
when ZnO NP was instilled at a dose of 10 mg/rat (37 mg/kg body
weight) (Chuang et al., 2014) or when ZnO NPwas given asmultiple
instillations of 17.5 mg/kg rat every second day for ﬁve weeks (Liu
et al., 2013). In our study mice exposed to 6 and 18 mg (study 1) and
15 mg (study 2) showed a signiﬁcant decrease in body weight of
more than 10%. It should be noted that a clear difference in toxicity
towards ZnO fumes has been observed in a test of 11 different
inbred mouse strains (Wesselkamper et al., 2001) making inter-
species difference very likely. It is especially noteworthy that
C57BL/6J (C57BL/6J and C57BL/6N was used in study 1 and 3,
respectively) was amongst the lowest responders with regards to
inﬂammation (PMNs) (10-fold) and protein concentration (1.1-fold)
in BALF following a single inhalation exposure vs air exposed
controls. BALB/c mice (similar to study 2) were more sensitive than
C57BL/6 in terms of these parameters. These results indicate that
even stronger responses might have been observed in our studies if
high responder strains had been used, e.g. C3H/HeOuJ and CBA/J
mice which showed a 555 and 420-fold increase in PMNs and a 3
and 2.4-fold increase in protein concentration vs air exposed con-
trols (Wesselkamper et al., 2001).
We hypothesize that leakage of ﬂuids to the lung is the direct or
at least partial cause for the observed mortality. In the pilot study,
within study 1, two mice were exposed to 162 mg ZnO NP. These
mice were killed off schedule after about 30 h. Their lungs were
completely ﬁlled with blood. Although at much lower levels, mice
exposed to 6 mg (study 1) showed epithelial damage, desquamation
and a concomitantly increased barrier permeability of the alveolar/
blood (2e3 days post-exposure). This was especially evident by the
large increase in red blood cells and protein in BALF. Results from
study 2 support these ﬁndings. Mice exposed to 15 mg showed a
strong increase in LDH, protein and IgM in BALF 1d post-exposure.
Similar results are generally observed in the literature (Ho et al.,
2011; Chuang et al., 2014) and are indicative of strong pulmonary
toxicity with cell death and injury to the alveolar barrier allowing
ﬂuids to enter the pulmonary space. Indeed, the detailed and dra-
matic cell death of alveolar epithelial cells, and therefore barrier
destruction has been studied in vitro (LA4-alverolar epithelial cells).
Toxicity was observed starting at very low concentrations (3 mg/
ml ZnO NP) and was not observed with e.g. 500 mg crystalline
silica (Min-U-Sil 5) (Beyerle et al., 2010). However, as mentioned
above mice have died from ZnO exposure via other routes; e.g. an
LD50 of 0.3 mg ZnO NP/kg body weight indicates other toxic
mechanisms not related to leakage of ﬂuid into the pulmonary
space.
Available data show that it is dissolution of Zn(II) ions from the
particles that is the major determinant for ZnO-mediated toxicity
and cell death (Landsiedel et al., 2014). Accordingly, NP are more
toxic than larger counterparts as the dissolution rate increases with
decreasing particle size (Meulenkamp, 1998). Additionally, ZnO
purity is important as e.g. dissolution is reduced by doping ZnO NP
with iron (Xia et al., 2011). Uptake in acidic endosomes and later
lysosomes accelerate dissolution leading to lysosomal damage,
mitochondrial disturbance, production of ROS and cytokines (Nel
et al., 2009). Similar effects have been observed in human cell
lines (Kao et al., 2012). In Cho and co-workers detailed work the
authors hypothesized that a rapid dissolution of ZnO NP inside
endosomes/lysosomes is the primary cause for severe lung injury
caused by ZnO NP (Cho et al., 2011). It is worth mentioning that the
mortality was observed in study 3 using the largest particle of the 3
studies (130 nm vs 12 and 70 nm in study 1 and 2, respectively).
Mortality was not observed in study 1 and 2 as these studies were
short term. However, this indicates that even stronger responses
(higher mortality) might have been observed in study 3 if even
smaller NP were used.
Mice surviving the initial exposure of ZnO NP up to 25 mg
(~1.35 mg/kg mouse body weight) appeared to have no effects
assessed on a number of markers of pulmonary inﬂammation and
barrier integrity 2 months post-exposure. However a dose of 50 mg
(~2.7 mg/kg mouse body weight) caused increased collagen accu-
mulation in the lungs. Fibrosis was identiﬁed at a time point when
all inﬂammatory end-points were similar to control levels indi-
cating a resolved inﬂammation. Additionally, the levels of collagen
were similar after exposure to 50 mg ZnONP and 2500 mg crystalline
silica. Cho and co-workers have previously shown that aspiration of
310 mg ZnO NP (~1.4 mg/kg rat body weight) caused “severe ﬁbrosis
and airway epithelial injury” and that the mechanism likely
involved Zn(II) ions. Instillation of Zn(II) ions (92.5 mg) caused both
ﬁbrosis and mortality (Cho et al., 2011).
In general ZnO NP caused a very strong inﬂammatory response
with neutrophils increasing between 4-and 7-fold in study 1 (2, 6
and 18 mg) and between 1.4 and 9-fold in study 2 (5 and 15 mg) 1d
post-exposure. End-points determined in study 1 and 2 (18 mg and
15 mg, 24 h post-exposure) were similar in fold-inductions with a
marginal tendency to stronger results in study 2 neutrophils,
lymphocytes and protein. Since study 1 incorporated a smaller
particle (12 nm vs 70 nm) and slightly larger dose (18 mg vs 15 mg)
the differences might be caused by the more responsive BALB/c
mice used in study 2. Inﬂammation is not in itself problematic if it is
resolved quickly. However, if not resolved inﬂammation may lead
to oxidative stress; an imbalance between production of reactive
oxygen/nitrogen species and antioxidant defense systems. Both
inﬂammation and oxidative stress are important mechanisms
implicated in particle-induced health effects such as cancer and
systemic effects (Moller et al., 2010, 2014, 2015). Whilst oxidative
stress markers are frequently assessed in vitro with ZnO they are
very seldom assessed in animal studies. Markers of oxidative stress
were determined in our study 2, where 15 mg of ZnO NP caused a
signiﬁcant increase of lipid oxidation and decrease of the antioxi-
dant glutathione. The antioxidant enzyme catalasewas increased at
the low dose but not in the high dose group. It is possible that low
doses of ZnO induce the antioxidant response via the Nrf2 pathway
and thus the expression of catalase, whereas larger doses of ZnO NP
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may deplete it. We also found that the local milieu affects genome
integrity. DNA damage was observed in the BALF cells 1d post-
exposure. However, this effect was not present 3d post-exposure.
Previously short term in vitro exposures have shown that ZnO NP
is a potent inducer of strand breaks and oxidatively damaged DNA
determined by comet assay (Gerloff et al., 2009).
Pulmonary exposure to ZnO also caused systemic effects. Several
blood parameters indicative of acute systemic inﬂammation was
altered in the 15 mg ZnO NP group. Histology of the liver showed an
increased regenerative activity by the presence of binucleated he-
patocytes and enlargement of single hepatocyte. In both study 1
and 2 systemic effects were stronger in animals receiving the high
dose (18 and 15 mg, respectively).
In summary, a bolus pulmonary exposure of 6 mg ZnO NP
(0.3 mg/kg mouse body weight) manifested severe signs of toxicity
in terms of reduced body weight, large acute pulmonary inﬂam-
mation and excessive desquamation of epithelial cells with
concomitant leakage of the alveolar barrier. Additionally, histology
revealed increased proliferation and hypertrophy of bronchiole
epithelial cells as well as lymphoid cell inﬁltration and oedema.
Increased number of binucleated cells and hypertrophy was
evident in the liver indicating systemic effects of a pulmonary bolus
dose of 6 mg ZnO NP. Higher doses of 15 and 18 mg ZnO NP yielded
stronger effects and animal suffering which lead to the termination
of experiments (study 1 and 2). Even higher bolus doses of ZnO NP
were clearly associatedwith a dose dependentmortality (25 up to
100 mg) and with collagen accumulation indicative of pulmonary
ﬁbrosis (50 mg).
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